Steve Seedhouse

Stock Analyst at Cantor Fitzgerald

(1.37)
# 1936
Out of 5,441 analysts
4
Total ratings
Success rate
Average return
4 Stocks
Name Action PT Current % Upside Ratings Updated
APLS Apellis Pharmaceutic...
Maintains: Overweight
39 40
23.87 67.57% 1 Aug 1, 2025
INVA Innoviva
Initiates Coverage On: Overweight
26
19.64 32.38% 1 Jul 11, 2025
TVRD Tvardi Therapeutics
Initiates Coverage On: Overweight
52
23.71 119.32% 1 Jul 11, 2025
HROW Harrow
Initiates Coverage On: Overweight
76
33.76 125.12% 1 Jul 11, 2025